DryShips, Eagle Bulk Shipping and Sierra Wireless lead small-cap volume in pre-market
DryShips Inc. (Nasdaq:DRYS), Eagle Bulk Shipping Inc. (Nasdaq:EGLE) and Sierra Wireless Inc. (Nasdaq:SWIR) are among the most actively traded companies in Friday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Also included among the results: AMAG Pharmaceuticals Inc. (Nasdaq:AMAG), James River Coal Co. (Nasdaq:JRCC), Applied Micro Circuits Corp. (Nasdaq:AMCC), Acme Packet Inc. (Nasdaq:APKT), S1 Corp. (Nasdaq:SONE) and Force Protection Inc. (Nasdaq:FRPT).
Acorda Therapeutics, Jos A Bank Clothiers and OmniVision Technologies lead small-cap volume in pre-market
Acorda Therapeutics Inc (Nasdaq:ACOR), Jos A Bank Clothiers Inc (Nasdaq:JOSB) and OmniVision Technologies Inc (Nasdaq:OVTI) are among the most actively traded companies in Monday's trading among companies with market capitalizations under $1 billion.
[ More » ]
Canadian Solar Inc (Nasdaq:CSIQ), Applied Micro Circuits Corp (Nasdaq:AMCC) and Iconix Brand Group Inc (Nasdaq:ICON) are also among the most actively traded companies. Here are the most actively traded companies among small caps:
Russell 2000 stays flat
April 23 (SmallCapInvestor.com) – The Dow and the Russell 2000 are moving sideways this morning as investors consolidate their gains after Friday’s rally. Among small caps, Gentex Corporation (Nasdaq: GNTX) beat analysts’ earnings estimates, while shares of Applied Micro Circuits Corporation (Nasdaq: AMCC) fell on news of lower quarterly revenue.
[ More » ]
At 11:41 AM the Russell 2000 was down 0.44 points, or 0.05 percent, to 828.42. The Dow Jones Industrial Average had lost 1.62 points, or 0.01 percent, to 12,960.36.
Pre-market: NMT Medical gets study approval
Shares of Boston-based medical technology company NMT Medical, Inc. (Nasdaq: NMTI) have moved up on news this morning that it received conditional approval from the U.S. Food and Drug Administration for its study of stroke and transient ischemic attack. NMT Medical plans to involve 800 patients in the study. Shares are up $0.09, or 0.62%, to $14.55.
[ More » ]
spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer spacer
|
|